References
-
1
World Health Organization
(WHO). Global Tuberculosis Report 2021.
Geneva: WHO;
2021.
https://www.who.int/publications/i/item/9789240037021 - 2 Chakaya J, Khan M, Ntoumi F, et al. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts. Int J Infect Dis. 2021 Mar 11; S1201–9712(21); 00193–4. DOI: 10.1016/j.ijid.2021.02.107
- 3 Togun T, Kampmann B, Stoker NG, Lipman M. Anticipating the impact of the COVID-19 pandemic on TB patients and TB control programmes. Ann Clin Microbiol Antimicrob. 2020 May 23; 19(1): 21. DOI: 10.1186/s12941-020-00363-1
- 4 Di Gennaro F, Gualano G, Timelli L, et al. Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital. Antibiotics (Basel). 2021 Mar 8; 10(3): 272. DOI: 10.3390/antibiotics10030272
- 5 Pontarelli A, Marchese V, Scolari C, et al. Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis. Travel Med Infect Dis. 2019 Jan–Feb; 27: 39–45. DOI: 10.1016/j.tmaid.2018.10.015
-
6
Villa
S,
Codecasa
LR,
Faccini
M, et al.
Tuberculosis among asylum seekers in Milan, Italy:
epidemiological analysis and evaluation of interventions.
Eur Respir J. 2019
Oct
31; 54(4):
1900896 . DOI: 10.1183/13993003.00896-2019 -
7
Boudville
DA,
Joshi
R,
Rijkers
GT. Migration and
tuberculosis in Europe. J Clin Tuberc Other Mycobact
Dis. 2020
Jan
7; 18:
100143 . DOI: 10.1016/j.jctube.2020.100143 -
8
World Health Organization
(WHO).
Consolidated guidelines on tuberculosis . Geneva: WHO; 7 July 2021.https://www.who.int/publications/i/item/9789240029415 -
9
Palmieri
F. Per il Gruppo di
Lavoro Tubercolosi-INMI “L. Spallanzani” Percorso Diagnostico
Terapeutico Assistenziale Sulla Gestione del Paziente con Infezione/Malattia
Tubercolare. Revisione N.
8/Gennaio
2020. Accessed 30 November 2021.
http://www.inmi.it/servizio/protocolli_e_linee_guida . -
10
European Centre for Disease
Prevention and Control & World Health Organization. Regional
Office for Europe. (2020).
Tuberculosis surveillance and monitoring in Europe 2020: 2018 data . World Health Organization. Regional Office for Europe.https://apps.who.int/iris/handle/10665/331530 . - 11 Kraef C, Bentzon A, Panteleev A, et al. Delayed diagnosis of tuberculosis in persons living with HIV in Eastern Europe: associated factors and effect on mortality-a multicentre prospective cohort study. BMC Infect Dis. 2021 Oct 6; 21(1): 1038. DOI: 10.1186/s12879-021-06745-w
- 12 Li J, Chung PH, Leung CLK, Nishikiori N, Chan EYY, Yeoh EK. The strategic framework of tuberculosis control and prevention in the elderly: a scoping review towards End TB targets. Infect Dis Poverty. 2017 Jun 1; 6(1): 70. DOI: 10.1186/s40249-017-0284-4
- 13 Di Gennaro F, Vittozzi P, Gualano G, et al. Active Pulmonary Tuberculosis in Elderly Patients: A 2016–2019 Retrospective Analysis from an Italian Referral Hospital. Antibiotics (Basel). 2020 Aug 7; 9(8): 489. DOI: 10.3390/antibiotics9080489
- 14 Kristensen KL, Ravn P, Petersen JH, et al. Long-term risk of tuberculosis among migrants according to migrant status: a cohort study. Int J Epidemiol. 2020 Jun 1; 49(3): 776–785. DOI: 10.1093/ije/dyaa063
- 15 Yen YF, Feng JY, Pan SW, Chuang PH, Su VY, Su WJ. Determinants of mortality in elderly patients with tuberculosis: a population-based follow-up study. Epidemiol Infect. 2017 May; 145(7): 1374–1381. DOI: 10.1017/S0950268817000152
- 16 Piergallini TJ, Turner J. Tuberculosis in the elderly: Why inflammation matters. Exp Gerontol. 2018 May; 105: 32–39. DOI: 10.1016/j.exger.2017.12.021
-
17
Ingrosso
L,
Vescio
F,
Giuliani
M, et al. Risk
factors for tuberculosis in foreign-born people (FBP) in Italy: a systematic
review and meta-analysis. PLoS One.
2014
Apr
14; 9(4):
e94728 . PMID: 24733156; PMCID: PMC3986251. DOI: 10.1371/journal.pone.0094728 - 18 Chemtob D, Ogum E. Tuberculosis treatment outcomes of non-citizen migrants: Israel compared to other high-income countries. Isr J Health Policy Res. 2020 Aug 3; 9(1): 29. PMID: 32741367; PMCID: PMC7397670. DOI: 10.1186/s13584-020-00386-1
- 19 Di Gennaro F, Pizzol D, Cebola B, et al. Social determinants of therapy failure and multi drug resistance among people with tuberculosis: A review. Tuberculosis (Edinb). 2017 Mar; 103: 44–51. DOI: 10.1016/j.tube.2017.01.002
- 20 Hargreaves S, Lönnroth K, Nellums LB, et al. Multidrug-resistant tuberculosis and migration to Europe. Clin Microbiol Infect. 2017 Mar; 23(3): 141–146. DOI: 10.1016/j.cmi.2016.09.009
- 21 Odone A, Riccò M, Morandi M, Borrini BM, Pasquarella C, Signorelli C. Epidemiology of tuberculosis in a low-incidence Italian region with high immigration rates: differences between not Italy-born and Italy-born TB cases. BMC Public Health. 2011 May 23; 11: 376. DOI: 10.1186/1471-2458-11-376
- 22 Di Gennaro F, Lattanzio R, Falanga C, et al. Low-Wage Agricultural Migrant Workers in Apulian Ghettos, Italy: General Health Conditions Assessment and HIV Screening. Trop Med Infect Dis. 2021 Oct 15; 6(4): 184. DOI: 10.3390/tropicalmed6040184
- 23 Merid MW, Gezie LD, Kassa GM, Muluneh AG, Akalu TY, Yenit MK. Incidence and predictors of major adverse drug events among drug-resistant tuberculosis patients on second-line anti-tuberculosis treatment in Amhara regional state public hospitals; Ethiopia: A retrospective cohort study. BMC Infect. Dis. 2019; 19: 286. DOI: 10.1186/s12879-019-3919-1
- 24 Lan Z, Ahmad N, Baghaei P, et al. Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis. Lancet Respir Med. 2020 Apr; 8(4): 383–394. DOI: 10.1016/S2213-2600(20)30047-3
- 25 Noor S, Ismail M, Khan F. Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects. Clin Respir J. 2021 Jan; 15(1): 97–108. DOI: 10.1111/crj.13276
-
26
Borisov
S,
Danila
E,
Maryandyshev
A, et al.
Surveillance of adverse events in the treatment of
drug-resistant tuberculosis: first global report.
Eur Respir J. 2019
Dec
19; 54(6):
1901522 . DOI: 10.1183/13993003.01522-2019 - 27 Holden IK, Andersen PH, Wejse C, Lillebaek T, Johansen IS. Review of tuberculosis treatment outcome reporting system in Denmark, a retrospective study cohort study from 2009 through 2014. BMC Health Serv Res. 2020 Feb 3; 20(1): 83. PMID: 32013962; PMCID: PMC6998178. DOI: 10.1186/s12913-020-4927-y
- 28 Peri AM, Bernasconi DP, Galizzi N, et al. Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study. BMC Infect Dis. 2018 Dec 20; 18(1): 690. DOI: 10.1186/s12879-018-3609-4
- 29 Pezzotti P, Pozzato S, Ferroni E, et al. Delay in diagnosis of pulmonary tuberculosis: A survey in the Lazio region, Italy Epidemiology Biostatistics and Public Health. 2015; 1–10: 12.
- 30 Koo HK, Min J, Kim HW, et al. Prediction of treatment failure and compliance in patients with tuberculosis. BMC Infect Dis. 2020 Aug 24; 20(1): 622. DOI: 10.1186/s12879-020-05350-7
- 31 Riccardi N, Pontarelli A, Alagna R, et al. Epidemiology and treatment outcome of MDR and pre-XDR TB in international migrants at two reference centers in the North of Italy: a cross-sectional study coordinated by Stop TB Italia Onlus. Public Health. 2020 Mar; 180: 17–21. DOI: 10.1016/j.puhe.2019.10.022
- 32 Aslam MV, Owusu-Edusei K, Marks SM, et al. Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States. Int J Tuberc Lung Dis. 2018; 22(12): 1495–1504. DOI: 10.5588/ijtld.18.0260
- 33 Nishikiori N, Van Weezenbeek C. Target prioritization and strategy selection for active case-finding of pulmonary tuberculosis: a tool to support country-level project planning. BMC Public Health. 2013; 13: 97. DOI: 10.1186/1471-2458-13-97
-
34
World Health Organization
(WHO). Implementing the end TB Strategy.
Geneva
2015.
https://www.who.int/publications/i/item/implementing-the-end-tb-strategy . -
35
Saunders
MJ,
Evans
CA. COVID-19,
tuberculosis and poverty: preventing a perfect storm.
Eur Respir J. 2020
Jul
9; 56(1):
2001348 . DOI: 10.1183/13993003.01348-2020 -
36
Di
Gennaro
F,
Marotta
C,
Antunes
M,
Pizzol
D. Diabetes in
active tuberculosis in low-income countries: to test or to take
care?
Lancet Glob Health. 2019
Jun; 7(6):
e707 . DOI: 10.1016/S2214-109X(19)30173-1
